MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
More news: Software
Written by / Agency / Source: Kenexa | IBM
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

IBM Patents Machine Learning Models for Drug Discovery - Invention could accelerate discovery of more effective and safer drugs - IBM.com
IBM Patents Machine Learning Models for Drug Discovery

 

NewswireToday - /newswire/ - Armonk, NY, United States, 2017/04/07 - Invention could accelerate discovery of more effective and safer drugs - IBM.com. NASDAQ: KNXA

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Software Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

IBM today announced that its scientists have been granted a patent on machine learning models to predict therapeutic indications and side effects from various drug information sources. IBM Research has implemented a cognitive association engine to identify significant linkages between predicted therapeutic indications and side effects, and a visual analytics system to support the interactive exploration of these associations.

This approach could help researchers in pharmaceutical companies to generate hypotheses for drug discovery. For instance, strongly correlated disease-side-effect pairs identified by the patented invention could be beneficial for drug discovery in many ways. One could use the side-effect information to repurpose existing treatments (e.g. drugs causing postural hypotension could be potential candidates for treating hypertension). If a new drug is being designed for a disease that is strongly correlated with severe side effects, then special attention could be paid to controlling the formulation and dosing of the drug in the clinical trials to prevent serious safety issues.

IBM was granted U.S. Patent 9,536, 194: Method and system for exploring the associations between drug side-effects and therapeutic indications for this invention.

Lack of efficacy and adverse side effects are two of the primary reasons a drug fails clinical trials, each accounting for around 30 percent of failures. Computational models and machine learning methods that can derive useful insights from large amounts of data on drugs and diseases from various sources hold great promise for reducing these attrition rates and improving the drug discovery process.

“As inventors at IBM, we have the opportunity to help solve real-world problems,” said Jianying Hu, Senior Manager and Program Director, Center for Computational Health, IBM Research. “Our team is dedicated to this research and we continue to search for new ways to improve people’s health around the world through innovation and invention.”

One of the research areas of the Center for Computational Health at IBM Thomas J. Watson Research Center is translational informatics, which focuses on the development of novel techniques to extract insights and knowledge from biological and clinical data to support biological scientists, clinicians, and patients.

IBM (ibm.com) has been working in this area for several years, and has developed a suite of advanced machine learning tools as well as computational models and platforms that can be used to derive insights from a wide variety of data sources (e.g. pharmacological knowledge bases) to help improve the efficiency and effectiveness of drug discovery and development. These methodologies have been applied to many specific use cases including drug repurposing (i.e. helping to find new uses for existing drugs in the market), indication expansion (i.e. helping to identify potential new indications for drugs still in various stages of a development pipeline), drug safety (i.e. helping to detect and predict a drug’s safety profiles) and personalized medicine (e.g. personalized efficacy/safety profile predictions).

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Software Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Kenexa | IBM

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
Software Warnings - IMPORTANT:
Always be aware/cautious about what you download on your computer/mobile! PURCHASE SOFTWARE related keywords / Banner Ads. Click HERE for details!
.

 
  Your Banner Ad showing on ALL
Software articles,
CATCH Visitors via Your Competitors Announcements!


IBM Patents Machine Learning Models for Drug Discovery

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Chris Blake - IBM.com 
415-613-1120 blakechr[.]us.ibm.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Kenexa | IBM securities in any jurisdiction including any other companies listed or named in this release.

Software via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Kenexa | IBM / Company Profile


Read Software Most Recent Related Newswires:

Independent Research Firm Names SAP a Leader in Data Management for Analytics
InterSystems Announces Enhanced Open Source Availability for InterSystems iKnow Technology
Centra Health Delivers Superior Patient Care with Oracle Cloud Applications
Oracle Announces Oracle Cloud Data Science Platform
Saba Recognized as a Strategic Leader in Fosway 9-Grid™ for Learning Systems for Sixth Consecutive Year
JDA Software Announces Company Name Change to Blue Yonder
Equinix Taps Oracle Exadata to Help Power Global Interconnection Platform
LapuLapu Leisure Goes Digital with Resort and Casino Project
Technicolor’s MPC has Won the Oscar® for Visual Effects on 1917 At The 92nd Academy Awards
More Industry-Leading Companies Across the Globe Choose SAP Ariba and SAP Fieldglass Solutions for Intelligent Spend Management
SAP Achieves First-Place Rankings in Internationally Recognized CeFPro Fintech Leaders 2020 Report
TIBCO Enhances Retail Capabilities in the Cloud on Amazon Web Services
Koch Industries Agrees to Acquire All of Infor
InterSystems Wins Two 2020 Best in KLAS Awards
SAP Extends its Innovation Commitment for SAP S/4HANA, Provides Clarity and Choice on SAP Business Suite 7

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2020 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)